Detalles de la búsqueda
1.
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.
Clin Infect Dis
; 72(11): e815-e824, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33043969
2.
Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I.
J Antimicrob Chemother
; 74(12): 3555-3564, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31430369
3.
Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I.
J Antimicrob Chemother
; 74(12): 3646-3647, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562501
4.
Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairment.
HIV Clin Trials
; 15(6): 269-73, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433666
5.
The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study.
Antivir Ther
; 27(4): 13596535221094898, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36000318
6.
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial.
Lancet Child Adolesc Health
; 5(9): 642-651, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34302760
7.
Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial.
Lancet HIV
; 5(7): e347-e356, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29925490
8.
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairment.
J Acquir Immune Defic Syndr
; 68(3): 310-3, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25469527
9.
Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor.
J Int AIDS Soc
; 17(4 Suppl 3): 19824, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397568
10.
Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
PLoS One
; 9(3): e92717, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24651857
11.
Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients.
Antivir Ther
; 18(6): 793-802, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23963249
12.
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
J Acquir Immune Defic Syndr
; 61(3): 302-9, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22842844
Resultados
1 -
12
de 12
1
Próxima >
>>